Cervical Cancer: Understanding, Preventing, and Rebuilding

Cervical Cancer: Understanding, Preventing, and Rebuilding

Cervical cancer remains a major public health issue, although it is increasingly controlled thanks to vaccination and screening programs.

In France, approximately 3,000 new cases are diagnosed each year, and just over 1,000 women still die from it each year. However, the figures also show a gradual decrease in incidence over several decades, evidence of the effectiveness of prevention efforts.

The cervix is a particularly vulnerable area of female anatomy. When persistently infected by certain types of human papillomavirus (HPV), it can develop precancerous lesions that, over time, evolve into cancer if not detected and treated.

HPV is a very common virus transmitted during sexual intercourse. In most cases, the body eliminates it naturally, but in some women, the infection persists and eventually causes cellular mutations.

A Long-Silent Cancer

The danger of cervical cancer lies in its silent progression. In its early stages, it causes no signs. It is only at a more advanced stage that the first symptoms appear: unusual vaginal bleeding (after sexual intercourse, between periods, or after menopause), persistent pelvic or lower back pain, or painful sexual intercourse.

This is why screening plays a crucial role. The Pap smear (cervical smear) is recommended every three years between the ages of 25 and 65, after two normal tests conducted one year apart. This simple procedure involves taking a few cells from the cervix using a small brush to look for precancerous lesions. In case of doubt, other examinations such as colposcopy, biopsy, or MRI can help clarify the extent of the disease.

Available Treatments

The therapeutic strategy is personalized. It is defined during a multidisciplinary consultation meeting (MCM) involving surgeons, oncologists, gynecologists, and radiotherapists. The choice of treatment depends on the patient's age, health status, and stage of the disease.

• Surgery is offered when the tumor is localized and small. It can range from partial removal to total hysterectomy, sometimes with the removal of lymph nodes.

• Radiotherapy uses targeted rays to destroy cancer cells. It is often combined with surgery or offered when surgery is not possible.

• Chemotherapy is indicated in more advanced or metastatic forms. Administered in several cycles, it remains a heavy but essential treatment in certain cases.

• Combined treatments allow, when necessary, to maximize the chances of recovery.

  Prevention: Vaccination and Lifestyle Hygiene

  The best weapon against this cancer remains prevention. HPV vaccination is now recommended not only for girls aged 11 to 14 but also for boys since 2021. It significantly reduces the risk of infection and thus the progression to cervical cancer.

  Regular screening remains essential, even for vaccinated women. Finally, certain behaviors can help reduce risks:

  - avoid tobacco,

  - maintain a balanced weight,

  - protect sexual health,

  - and consult as soon as unusual symptoms appear.

  Reconstruction After Cancer: RENASCOR Expertise

  A cancer does not stop at medical recovery. Heavy treatments such as radiotherapy or chemotherapy often lead to hair loss and a deterioration of self-image. This is where the RENASCOR Laboratory, a global expert in post-cancer hair reconstruction, intervenes.

  • With REDACTIV1®, a unique gel serum, RENASCOR supports patients from the end of treatments to stimulate microcirculation and reactivate dormant hair follicles.

  • When the hair reaches about 1 cm, the transition is ensured by REDACTIV2®, a growth serum that promotes hair density and vitality.

  • Partner socio-hairdressers and socio-estheticians of RENASCOR also contribute to psychological and aesthetic reconstruction, helping each patient regain confidence and femininity.

    Because the fight against cancer is not limited to saving lives but also to restoring dignity and self-esteem, RENASCOR is committed daily alongside patients.

    Key Takeaways

    • In France, approximately 3,000 new cases of cervical cancer are diagnosed each year.

    • The main cause is persistent infection by human papillomavirus (HPV).

    • Regular screening and HPV vaccination are the best prevention weapons.

    • Treatments are personalized, ranging from surgery to chemotherapy.

    • The RENASCOR Laboratory offers unique solutions to support post-cancer hair and aesthetic reconstruction, so that every woman can regain her femininity and confidence.